Zhenkun Liu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Case Report: Long-term TCR repertoire dynamics in a disease-free survival stage IIIB-N3 lung adenocarcinoma patient treated with anti-PD-1 followed by surgery.
Journal: Frontiers in immunology
Published: March 23, 2026
Effects of Esketamine on Postoperative Cognitive Function in Elderly Patients Undergoing Pulmonary Lobectomy: A Randomised, Single-Blind Controlled Clinical Trial.
Journal: Actas espanolas de psiquiatria
Published: December 24, 2025
Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment.
Journal: Molecular aspects of medicine
Published: May 19, 2025
Complete resection after abemaciclib targeted therapy in a patient with mediastinal liposarcoma extensively invading the pericardium and major vessels.
Journal: Asian journal of surgery
Published: November 13, 2023
Response to savolitinib in a patient with lung adenocarcinoma harboring a novel MET exon 14 skipping mutation.
Journal: Asian journal of surgery
Published: November 12, 2023
Coexistence of a novel intergenic (between CHST2 and SLC9A9)-ALK, TNIK-ALK double-fusion in resected lung adenocarcinoma.
Journal: Asian journal of surgery
Published: October 26, 2023
Circulating tumor DNA- and cancer tissue-based next-generation sequencing reveals comparable consistency in targeted gene mutations for advanced or metastatic non-small cell lung cancer.
Journal: Chinese medical journal
Published: October 15, 2023
Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: progress in basic research and clinical application.
Journal: Frontiers in immunology
Published: October 12, 2023
Do elderly patients with stage I-IIA small cell lung cancer obtain survival benefits from surgery? A propensity score matching study.
Journal: Asian journal of surgery
Published: July 09, 2023
A novel intergenic (between REG3A and CTNNA2-AS1)-ALK fusion responds to alectinib in lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 04, 2023
Complete pathological response and negative postoperative ctDNA were not predictive of discontinuation of adjuvant crizotinib therapy in a patient with locally advanced MET ex14 skipping mutation-positive non-small cell lung cancer: a case report.
Journal: Frontiers in oncology
Published: February 13, 2023
Last Updated: 09/26/2026